
	Where results make sense

Topic: Novartis

Related Topics

Sandoz Laboratories

Lists of companies

Pharmaceutical company

Eli Lilly and Company

Lundbeck

Drug companies

AstraZeneca

Bally

Abbott Laboratories

Swisscom

List of company name etymologies

Swiss Re

GlaxoSmithKline

Bayer

Ciba Specialty Chemicals

	Novartis - Wikipedia, the free encyclopedia
		Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland.
		Novartis was created in 1996 from the merger of CIBA-Geigy and Sandoz Laboratories, both Swiss companies with long individual histories.
		Novartis combined its agricultural division with that of AstraZeneca to create Syngenta in November of 2000.
	en.wikipedia.org /wiki/Novartis (215 words)

	Novartis in licensing deal on Hep C drug - Boston.com - Europe - News (Site not responding. Last check: 2007-10-07)
		Novartis has signed an exclusive licensing agreement with Anadys Pharmaceuticals for a hepatitis drug and may pay Anadys up to $570 million, the firms said on Thursday.
		Novartis obtains the right to develop, manufacture and commercialize the drug called ANA975 -- currently in Phase I trials -- to treat chronic hepatitis C, as well as to develop it for other indications, including hepatitis B infection.
		The bank argued that Novartis had underperformed Roche this year and that the market perception of Novartis was changing, helped by growing expectations of positive news from the Basel-based firm.
	www.boston.com /news/world/europe/articles/2005/06/02/novartis_in_licensing_deal_on_hep_c_drug (382 words)

	Bloomberg.com: Europe (Site not responding. Last check: 2007-10-07)
		Novartis relied on $66 million in financial income for the fourth quarter's 1 percent increase in profit, and the results fell short of the $1.45 billion expected by seven analysts surveyed by Bloomberg News.
		Novartis said new data from the second and third phases of testing generally required for regulatory approval, showed SPP100, also known as Aliskiren, is effective when used alone and helps Diovan work better when taken together.
		Novartis repeated that its experimental drug ICL670 was effective at removing excess iron from the blood in a late-stage study originally presented last month.
	www.bloomberg.com /apps/news?pid=10000085&sid=aM5wz760qZm0&refer=europe (1096 words)

	IFPMA Health Initiatives: Participating Companies: Novartis
		Novartis is committed to supporting research on diseases of poverty and has recently established the Novartis Institute for Tropical Diseases in Singapore.
		For its employees and their families in the developing world, Novartis has established a comprehensive program of medical services that includes free or heavily subsidized facilities for diagnosis, treatment, and psychosocial care of workers with HIV/AIDS or other poverty-related diseases such as TB or malaria.
		Novartis donates intraocular lenses to NGOs for cataract surgery for patients with inadequate means in developing countries.
	www.ifpma.org /Health/participate/health_novartis_part.aspx (447 words)

	Novartis Corporation
		Novartis was born in 1997 from the merger of the Swiss-based pharmaceutical companies, Ciba-Geigy and Sandoz.
		Novartis in Ireland was formed in March 1997 following the merger of Ciba and Sandoz.
		Novartis currently employs more than 400 people in its manufacturing facility in Ringaskiddy, Co. Cork and its ethical pharmaceutical division based in Dublin.
	www.ie.novartis.com (323 words)

	Novartis Prize for Diabetes
		Novartis is a global leader in the Life Sciences, committed to improving health and well-being through the development of innovative products.
		Diabetes and obesity are major cardiovascular risk factors and Novartis Pharma AG is operating numerous research programs that are investigating potential new medications in these areas, with the aim of adding to the company's existing strengths in the fields of hypertension and dyslipidemias.
		Novartis Pharma AG has recently entered into the diabetes therapeutic area with a novel treatment for type 2 diabetes.
	www.diabetesaward.novartis.com /public/commitment.htm (200 words)

	Novartis - Corporate Profiles (Site not responding. Last check: 2007-10-07)
		Novartis, named after the Latin for "new skills", is one of the leading European biotechnology corporations.
		Novartis has a better understanding of the cultural sensibilities of European mentality and therefore has better protected itself from media.
		Novartis favours open "apologies" to the public over the GM foods furore as part of a waiting game: the corporation estimates that its European consumers will have accepted GM foods within 10 years.
	www.groundup.org /novartis/intro.htm (551 words)

	Privacy Policy - Novartis.com
		Novartis may transfer your data to one of its databases outside your country of domicile.
		In contrast, where Novartis believes that certain product, health, or other information is of importance to you it reserves the right to inform you by e-mail whilst giving you the choice of opting out of such service.
		Novartis will not knowingly collect, use or disclose personal data from a minor under the age of 13, without obtaining prior consent from a person with parental responsibility (e.g., a parent or guardian) through direct off-line contact.
	www.milbemite.novartis.us /privacy_policy.shtml (1230 words)

	Novartis Institute for Tropical Diseases - Mission - NITD
		The long-term aim of Novartis is to help reduce the overall affliction of tropical diseases and ultimately, improve the prosperity of developing countries.
		Novartis is not responsible for the content or practices of any non-Novartis site.
		The Novartis Foundation aims to improve the quality of life of the poorest people in developing countries through a number of programs.
	www.nitd.novartis.com /mission/index.shtml (368 words)

	Novartis in the Philippines (Site not responding. Last check: 2007-10-07)
		Novartis was founded in December 1996 by combining the two Swiss-based companies Ciba-Geigy AG and Sandoz AG.
		Novartis is one of the world leading companies with core businesses in Healthcare (Pharmaceuticals, Opthalmics and Animal Health) and Consumer Health (self-medication, Nutrition).
		Novartis Healthcare Philippines was incorporated in March 1997, integrating Ciba-Geigy (Phils.) and Sandoz Philippines, following the merger of their parent companies.
	www.ph.novartis.com (223 words)

	BW Online \| May 26, 2003 \| Novartis
		There, Novartis was a midtier player -- certainly no match for Merck (MRK) & Co. or Pfizer (PFE) Inc. But Vasella, a physician himself, devoted every penny he could find to marketing and research and took the world by surprise in May, 2001, with Glivec, one of the most effective new cancer therapies going.
		"Novartis is emerging as one of the premier powerhouses in the global pharmaceuticals industry," says Richard R. Stover, senior analyst with brokerage Natexis Bleichroeder Inc. in New York.
		Novartis' boss is an unusual mix, an aggressive manager who still keeps something of the gentle bedside manner he developed as a general practitioner.
	www.businessweek.com /magazine/content/03_21/b3834021_mz044.htm (2391 words)

	Welcome to Novartis India Limited - Pharmaceuticals (Site not responding. Last check: 2007-10-07)
		Novartis was formally founded on December 20, 1996 when it was entered in the register of Companies in Switzerland.
		The formation of Novartis India Limited was a major event for all shareholders and employees of the two companies, Sandoz (India) Limited and Hindustan Ciba - Geigy Limited.
		Novartis offers hope to epileptic patients through Tegrital which has a wide range of activity and is arguably one of the most useful anti - epileptic drugs currently available.
	www.in.pharma.novartis.com (548 words)

	[No title]
		Novartis Pharma AG and Schering AG announced today that the analysis of progression free survival (PFS) as assessed by central radiology review in the CONFIRM 1 trial with the investigational drug PTK/ZK did not achieve statistical significance.
		Novartis and Schering now anticipate filing for approval with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) in early 2007.
		Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
	dominoext.novartis.com /NC/NCPRRE01.nsf/44aff02a639be034c1256b4b007b5f4d/a9455779de83d591c1256fca0081816e?OpenDocument (722 words)

	Novartis Care Plan
		Novartis is a founding member of Together Rx, LLC, an alliance of seven major pharmaceutical companies offering valuable savings on more than 150 medicines through one easy-to-use, completely free prescription drug savings card – the Together Card™.
		Novartis has a comprehensive and flexible prescription savings plan that offers help to a broad range of lower income patients enrolled in Medicare without presrciption drug coverage.
		Novartis is offering valuable savings on its prescription medications to fit the needs of low income patients enrolled in Medicare without prescription drug coverage.
	www.careplan.novartis.com /about.html (799 words)

	Novartis Moving Worldwide Research Headquarters to Boston Area - Site Selection Online Insider
		Novartis wasted no time in dipping its toe into the local talent pool.
		Novartis, in fact, was so sold on Cambridge as the right site for its new strategy that it reportedly turned down state officials' offers of assistance.
		Novartis, however, is the first major drug company to base its global research in Cambridge.
	www.conway.com /ssinsider/bbdeal/bd020520.htm (1114 words)

	Novartis Australia home page
		Novartis Australia is a leading provider of innovative solutions to improve health and well-being.
		Novartis also provides solutions to enhance eye care, animal care and meet the nutritional needs of ill people.
		Novartis employs more than 500 people across Australia, and invests over $27m annually in local research and related activity.
	www.novartis.com.au (152 words)

	Novartis Slims Down Insecticide Product Line -- Agrow, February 09, 1998
		Novartis is to slim down its insecticide range of 26 active ingredients to focus largely on 11 key a.i.s.
		Novartis has already taken the first step towards redefining its insecticide portfolio with the sale of its spray-on Bacillus thuringiensis biopesticide business to Thermo Trilogy in 1997 (Agrow No 291, p 1).
		Novartis is aware that some products are of considerable importance in local markets in Asia and Africa, and it is liaising with local authorities, non-governmental organisations and international organisations such as the World Bank and the United Nations Development Programme about its intentions.
	www.pmac.net /novartis.htm (1435 words)

	Careers - Novartis.co.uk
		Novartis is an international company with 81 000 employees operating in over 140 countries worldwide. We are organised into three business areas - Pharmaceuticals, Consumer Health and Sandoz, our generics divison.
		The UK is a dynamic and vibrant contributer to Novartis world-wide.
		Key to success in our company is the drive and desire of our people to really make a difference to health and well-being whilst simultaneously developing themselves and their career.
	www.novartis.co.uk /careers/index.shtml (188 words)

	[No title] (Site not responding. Last check: 2007-10-07)
		For Novartis, the pharmaceutical giant that takes its name from that term, the key to success is found in both developing new arts and leveraging previous experience.
		Novartis wanted to find a means to combine and manage the resources and knowledge of two previously independent companies into a coherent and accessible knowledge base.
		Most significant are the savings resulting from improved efficiency and productivity of Novartis lab personnel and program managers, who now have instant access to various research program documents and records, and no longer need to re-create documents for a dossier when they cannot be found.
	www.documentum.com /customer_success/success/novartis.htm (829 words)

	[No title] (Site not responding. Last check: 2007-10-07)
		A working hypothesis included a potential spin-off of non-core Aventis and Novartis products into a new entity that would preserve jobs, specifically in France and Germany, creating a pharmaceutical company with product development, licensing and commercial operations including manufacturing.
		Although the business case looks viable, the negative attitude of the French Government has influenced Novartis' consideration to a point that it will only enter into a negotiation phase if formally invited by the Aventis Supervisory Board and if the French Government assumed a neutral position.
		Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health.
	dominoext.novartis.com /NC/NCPRRE01.nsf/44aff02a639be034c1256b4b007b5f4d/e50e3e2ac3286f27c1256e60004a677c?OpenDocument (285 words)

	The New York Times: Search > Topic: NOVARTIS
		Daniel L. Vasella has been chief executive of Novartis, the Swiss pharmaceutical company, since it was formed in a 1996 merger of Sandoz with Ciba-Geigy.
		Novartis, the Swiss drug maker, agreed Wednesday to pay two British companies up to $375 million for an experimental treatment for chronic obstructive pulmonary disease, also known as smokers' lung.
		Novartis, the Swiss pharmaceutical giant, said on Monday that it planned to buy Hexal of Germany and its affiliate Eon Labs of New York for $8.4 billion in cash, creating the world's biggest maker of generic drugs.
	query.nytimes.com /search/query?ppds=org&v1=NOVARTIS&fdq=19960101&td=sysdate&sort=newest&ac=NOVARTIS&rt=1,des,org,per,geo (655 words)

	Welcome to Novartis (Thailand) Limited
		Novartis (Thailand) Limited has total revenues in 2004 of USD 71.3 Million or THB 2,852,000,000 (+17.4 %) that were pharmaceutical sales USD 36.8 million or THB 1,472,000,000 (+22.7%) and consumer health sales USD 34.5 million or THB 1,380,000,000 (+12.2%).
		Novartis Pharmaceuticals Division represents over 50% of the total Novartis business in Thailand, led by marketing-leading in the areas of cardiovascular medicine, oncology, hypertension, osteoporosis and diseases of the central nervous system.
		Novartis recognizes its role as a Corporate Citizen; we operate sustainable; we respect highest standards to protect the environment; we maintain strict compliance with the Code of Conduct and we engage extensively in patient assistance programs as well as community support projects around the world.
	www.th.novartis.com (375 words)

	Novartis Animal Health US, Inc.
		Novartis Animal Health's livestock business was formerly known as Novartis Animal Vaccines, Inc., which was formed in January 2002, incorporating the product lines of Grand Laboratories and ImmTech, LLC.
		U.S. headquarters are in Greensboro, N.C. Novartis was formed in 1996 through the merger of Sandoz and Ciba, two giants in the pharmaceutical industry.
		Novartis is still headquartered in Basel, Switzerland and operates in 140 countries.
	livestock.novartis.com /history.html (349 words)

	Novartis Consumer Health
		Our products are administered under professional guidance or over the counter direct to the patient, so we can meet their nutritional needs whether they be in hospitals, nursing homes or their own homes.
		Novartis is the third largest animal health company in Australia and a leader in parasite control products for sheep, cattle and pets.
		In Australia, we are at the forefront of international animal health research and development, boasting a key worldwide research facility which is actively seeking solutions to the highly diverse diseases and needs of animals.
	www.novartis.com.au /consumer_health.html (457 words)

	Novartis, an innovative healthcare products company - Novartis.com
		Novartis delivers strong growth in first nine months of 2005, on track to achieve full-year sales and earnings objectives
		Bagamoyo, Tanzania, October 17, 2005 – International experts at a symposium sponsored by the Novartis Institute for Tropical Diseases (NITD) are meeting to review advances in research on tuberculosis (TB) therapies.
		Novartis is raising awareness about osteoporosis with the IOF.
	www.novartis.com (266 words)

	NOVARTIS BREAKS PROMISE: ITS GERBER BABY FOOD CONTAINS MASSIVE AMOUNTS OF GENETICALLY ENGINEERED SOYA (Site not responding. Last check: 2007-10-07)
		“Are Novartis‘ promises only valid in rich countries and not in poor ones such as the Philippines?“ asked Greenpeace Southeast Asia campaigner in the Philippines Beau Baconguis while presenting the test results at a press conference in Manila (Philippines) this morning.
		This was reiterated by Novartis US spokesperson Al Piergallini, who was quoted in the Wall Street Journal Europe of 30 July 1999 saying: “I want our mothers to be comfortable“.
		Greenpeace is now urging Novartis to respect its own pledges not only in rich nations but in all countries.
	archive.greenpeace.org /pressreleases/geneng/2001aug21.html (599 words)

	Career center for job seekers - Novartis.com
		Novartis prefers to recruit candidates directly, rather than through a third party recruiter or agency.
		Novartis will only pay a fee for candidates submitted or presented where there is a signed recruiting agreement in place between Novartis and the recruiter or agency prior to the submittal, and the candidate is submitted for a specific requisition.
		In the case of candidate(s) submitted or presented to Novartis by a recruiter or agency without a signed agreement, Novartis explicitly reserves the right to pursue and hire those candidate(s) without any financial obligation to the recruiter or agency.
	www.novartis.com /careers/en/index.shtml (338 words)

Try your search on: Qwika (all wikis)